Superior Renal Function Sustained for 24 Months through Early Everolimus-Facilitated Reduction of Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients: Results of a Randomized Trial

被引：0
|
作者：
De Simone, P. [1 ]
Detry, O. [1 ]
Kintmalm, G. [1 ]
Goss, J. [1 ]
McCormick, P. [1 ]
Rossi, M. [1 ]
Moya, A. [1 ]
Lopez, P. [2 ]
Junge, G. [2 ]
Dong, G. [3 ]
Joseph, D. [3 ]
Duvoux, C. [1 ]
机构：
[1] H2304 Study Grp, Pisa, Italy
[2] Novartis Pharma AG, Basel, Switzerland
[3] Novartis Pharmaceut, E Hanover, NJ USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：169 / 170
页数：2
相关论文
共 50 条
  • [1] Everolimus-Facilitated Reduction Of Tacrolimus Provides Comparable Efficacy And Superior Renal Function Versus Standard Tacrolimus In De Novo Liver Transplant Recipients: 24-Month Results Of A Randomized Trial
    Saliba, Faouzi
    De Simone, Paolo
    Nevens, Frederik
    De Carlis, Luciano
    Metselaar, Herold
    Beckebaum, Susanne
    Jonas, Sven
    Sudan, Debra
    Fischer, Lutz
    Fung, John J.
    Dong, Gaohong
    Lopez, Patricia M.
    Junge, Guido
    [J]. HEPATOLOGY, 2012, 56 (06) : 1519 - 1519
  • [2] EARLY EVEROLIMUS PLUS REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS RESULTS IN SUPERIOR RENAL FUNCTION AND SUSTAINS OVER 24 MONTHS: RESULTS OF A RANDOMIZED TRIAL
    De Simone, P.
    Fischer, L.
    Kaiser, G.
    Jonas, S.
    Heise, M.
    Schemmer, P.
    Pascher, A.
    Schlitt, H.
    Paulus, E.
    Mertens, M.
    Duvoux, C.
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 3 - 3
  • [3] Everolimus-Facilitated Reduction of Tacrolimus Maintains Comparable Efficacy and Better Renal Function Versus Standard Tacrolimus in De Novo Liver Transplant Recipients.
    De Simone, P.
    Jones, R.
    Kohli, V.
    Gedaly, R.
    Jeffrey, G.
    Cantisani, G.
    Dong, G.
    Joseph, D.
    Lopez, P.
    Junge, G.
    Nevens, F.
    [J]. LIVER TRANSPLANTATION, 2013, 19 : S131 - S131
  • [4] Everolimus-Facilitated Tacrolimus Minimization Preserves Renal Function in De Novo Renal Transplant Recipients
    Shihab, F.
    Qazi, Y.
    Kaplan, B.
    Kim, D.
    Mulgaonkar, S.
    Peddi, V.
    Shaffer, D.
    Patel, D.
    McCague, K.
    Vincenti, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 538 - 539
  • [5] Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation
    Chapman, William C.
    Brown, Robert S.
    Chavin, Kenneth D.
    Sudan, Debra
    Koneru, Baburao
    Junge, Guido
    Dong, Gaohong
    Patel, Dharmesh
    Teperman, Lewis
    Fung, John J.
    [J]. TRANSPLANTATION, 2017, 101 (02) : 341 - 349
  • [6] Everolimus-Facilitated Tacrolimus Minimization Preserves Renal Function in De Novo Renal Transplant Recipients.
    Shihab, F.
    Qazi, Y.
    Kaplan, B.
    Kim, D.
    Mulgaonkar, S.
    Peddi, V.
    Shaffer, D.
    Patel, D.
    McCague, K.
    Vincenti, F.
    [J]. TRANSPLANTATION, 2014, 98 : 538 - 539
  • [7] Everolimus-Facilitated Reduction of Tacrolimus in De Novo Liver Transplant Recipients Achieves Comparable Overall Efficacy with Fewer Biopsy-Proven Acute Rejections Versus Standard Tacrolimus: 24-Month Results of a Randomized Trial
    Fung, J.
    Chavin, K.
    Moysyuk, Y.
    Orloff, S.
    Yantorno, S.
    Jones, R.
    Neuhaus, P.
    Dong, G.
    Lopez, P.
    Junge, G.
    Nevens, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 118 - 118
  • [8] Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial
    Nashan, Bjorn
    Schemmer, Peter
    Braun, Felix
    Dworak, Markus
    Wimmer, Peter
    Schlitt, Hans
    [J]. TRIALS, 2015, 16
  • [9] Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial
    Bjorn Nashan
    Peter Schemmer
    Felix Braun
    Markus Dworak
    Peter Wimmer
    Hans Schlitt
    [J]. Trials, 16
  • [10] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 24 MONTHS
    Duvoux, C.
    Saliba, F.
    Durand, F.
    Neau-Cransac, N.
    Hardwigsen, J.
    Pageaux, G.
    Boleslawski, E.
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 2 - 2
12345